Defence Therapeutics (TSE:DTC) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Defence Therapeutics Inc. announces the addition of molecular and antibody research expert Dr. Elias Theodorou to its board of directors, enhancing its scientific expertise. Dr. Theodorou, with over 25 years of experience, will provide guidance for Defence’s development, particularly in the USA. Additionally, the company appointed Mr. Arnab De as CFO and Corporate Secretary.
For further insights into TSE:DTC stock, check out TipRanks’ Stock Analysis page.
